BacharSamraMD

Oncology • Albuquerque, NM

Hematologic Oncology

Physician

Join to view full profile

Dr. Samra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Samra's full profile

Already have an account?

Office
8300 Constitution Ave NE
Albuquerque, NM 87110
Phone+1 505-559-6100

Fax+1 505-559-6649

Summary

I am a board certified hematologist and medical oncologist. I provide a general and comprehensive care for cancer and blood disorders to the local community. My clinical expertise is hematologic malignancies especially leukemia. I focus in my practice on patient education and empowerment as part of a shared decision making. I aspire to deliver the highest standards of clinical care, to diminish the gap of healthcare disparities, and to help guide my patients through their difficult journey.

Education & Training

University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2019 - 2020
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2013 - 2016
St Joseph's University Medical SchoolClass of 2012

Certifications & Licensure

NM State Medical License 2019 - 2026
TX State Medical License 2024 - 2025
OK State Medical License 2015 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

ASH Abstract Achievement Award American Society of Hematology, 2019
Chief Fellow-Hematology/Oncology SUNY Downstate, 2018-2019

Publications & Presentations

PubMed

8 citations
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, Joseph D. Khoury, Kiyomi Morita, Farhad Ravandi, Guillaume Richard-Carpentier
Blood Advances. 2021-10-26
39 citations
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of the...
Koji Sasaki, Hagop M. Kantarjian, Nicholas J. Short, Bachar Samra, Joseph D. Khoury
Cancer. 2021-08-01
34 citations
Targeting the VEGF Pathway in Osteosarcoma.
Tarek Assi, Sarah Watson, Bachar Samra, Elie El Rassy, Axel Le Cesne
Cells. 2021-05-18

Books/Book Chapters

Chronic leukemia a disease to conquer: types and treatment
Chapter: Chronic Lymphocytic Leukemia
Bachar Samra, Maher Abdul-HayOMICS Publishing Group2015

Abstracts/Posters

Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Bachar Samra, Hagop M. Kantarjian, Koji Sasaki, Marina Y Konopleva, Rita Khouri, Susan M. O'Brien, Alessandra Ferrajoli, Cesar Nunez, Tapan M. Kadia, Elias Jabbour, American Society of Hematology (ASH) 2019 Annual Meeting, Orlando, FL, 12/2/2019
Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)
Bachar Samra, Hagop M. Kantarjian, Koji Sasaki, Nicholas J. Short, Rita Khouri, Joseph D. Khoury, Richard E. Champlin, Partow Kebriaei, Jorge E. Cortes, Jeffrey L. Jor..., American Society of Hematology (ASH) 2019 Annual Meeting, Orlando, FL, 12/2/2019
Prognostic Factors for Progression in Patients (pts) with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) in Complete Molecular Response (CMR) w...
Koji Sasaki, Hagop M. Kantarjian, Bachar Samra, Nicholas J. Short, Joseph D. Khoury, Rashmi Kanagal-Shamanna, Marina Y Konopleva, Nitin Jain, Courtney D. DiNardo, Rita..., American Society of Hematology (ASH) 2019 Annual Meeting, Orlando, FL, 12/1/2019
Characteristics and Outcomes of Therapy-Related Versus De Novo Acute Myeloid Leukemia with Normal Karyotype
Bachar Samra, Guillaume Richard-Carpentier, Farhad Ravandi, Tapan M. Kadia, Veronica A Guerra, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Prithviraj Bose, Mu..., American Society of Hematology (ASH) 2019 Annual Meeting, Orlando, FL, 12/1/2019
Tyrosine phosphorylation of p27Kip1 associates with Palbociclib responsiveness in breast cancer
Stacy W. Blain, Susan R.S. Gottesman, Jonathan Somma, Vladislav Tsiperson, Julia McGuinness, Matthew Ingham, Kevin Kalinsky, Gary Schwartz, Elina Tress, Hanina Hibshoo..., American Association for Cancer Research (AACR) Annual Meeting 2019, Atlanta, GA, 4/2/2019
Atypical Immunophenotype Predicts Worse Prognosis in Adult T-Cell Lymphoma/Leukemia: A Retrospective Study of 63 Caribbean Patients at a New York City Tertiary Center
Bachar Samra, Edwin Chiu, Bo Lin, Eric Tam, Babak Baseri, Iuliana Shapira, Jason Gonsky, Robert David Lewis, Gurinder Sidhu, Ahmed Sawas, Evelyn O. Taiwo, American Society of Hematology (ASH) 2018 Annual Meeting, San Diego, CA, 12/3/2018
Join now to see all